Clinical Trial: Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Randomized-Withdrawal, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Subjects With Behcet's Disease Uveitis

Brief Summary: The objective of this study is to assess the efficacy and safety of gevokizumab in treating Behcet's disease uveitis (BDU).

Detailed Summary:
Sponsor: XOMA (US) LLC

Current Primary Outcome: Time to first ocular exacerbation [ Time Frame: Randomization through Day 280 ]

Time to first ocular exacerbation is defined as the number of days from randomization to the first ocular exacerbation.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: XOMA (US) LLC

Dates:
Date Received: October 2, 2014
Date Started: November 2014
Date Completion:
Last Updated: December 28, 2015
Last Verified: December 2015